bioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing

Mérieux, a world leader in the field of in vitro diagnostics, announces the launch of BIOFIRE® SPOTFIRE® for pharmaceutical industries, where this innovative molecular testing system is designed to ...
Daily Mirror

Asiri Laboratories introduces SL’s 1st rapid infectious disease diagnostic system

In a landmark step toward advancing infectious disease diagnostics, Asiri Laboratories has introduced the BioFire FilmArray ...
Becker's Hospital Review

HealthTrust, BioFire sign purchasing agreement

Brentwood, Tenn.-based HealthTrust has offered a purchasing agreement to Salt Lake City-based BioFire Diagnostics, a molecular biology company. The new agreement offers HealthTrust members BioFire’s ...
Firefighter Nation

BioFire Awarded Next Generation Diagnostics System Contract

SALT LAKE CITY, Utah (March 26, 2013) — BioFire Diagnostics, Inc. today announced that it has signed a competitive prototyping contract with the Department of the Army for Increment 1 of the Next ...
Nasdaq

bioMérieux submits enhanced BIOFIRE® BCID2 Panel for FDA clearance

MARCY L’ÉTOILE, France--(BUSINESS WIRE)-- Regulatory News: bioMérieux (Paris:BIM), a world leader in the field of in vitro diagnostics, announces that BioFire Diagnostics, its molecular biology ...
The Sunday Times

Asiri introduces SL’s first Rapid Infectious Disease Diagnostic System

Asiri Laboratories has introduced the BioFire® FilmArray® System — a cutting-edge multiplex PCR platform that transforms pathogen detection with speed, accuracy, and confidence. This breakthrough ...